Quick Takeaways
- James B. Murray Jr. filed SCHEDULE 13G for Acumen Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (ABOS).
- Disclosed ownership: 5%.
- Date of event: 04 Apr 2025.
James B. Murray Jr. - 04 Apr 2025 SCHEDULE 13G Report for Acumen Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (ABOS)
- Filing Manager
- James B. Murray Jr.
- Reporting Manager
- James B. Murray Jr.
- Symbol
- ABOS
- Shares outstanding
- 72,227,200 shares
- Disclosed Ownership
- 3,611,360 shares
- Ownership
- 5%
- Form type
- SCHEDULE 13G
- Filing time
- 07 Apr 2026, 16:05:05 UTC
- Date of event
- 04 Apr 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"James B. Murray Jr. disclosed 5% ownership in Acumen Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (ABOS) on 04 Apr 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 07 Apr 2026, 16:05.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| James B. Murray Jr. | 5% | 3,611,360 | 3,468,465 | 142,895 | /s/ James B. Murray, Jr. | James B. Murray, Jr. |